2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
43
Myelodysplastic Syndromes
41
Leukemia
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Leukemia, Lymphocytic, Chronic, B-Cell
23
Lymphoma
22
Hodgkin Disease
22
Hematologic Neoplasms
22
Multiple Myeloma
18
Graft vs Host Disease
14
Myeloproliferative Disorders
13
Primary Myelofibrosis
12
Leukemia, Myelomonocytic, Juvenile
11
Lymphoma, Mantle-Cell
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myelomonocytic, Chronic
7
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myeloid, Accelerated Phase
6
Congenital Abnormalities
6
Burkitt Lymphoma
6
Waldenstrom Macroglobulinemia
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Myeloid, Chronic-Phase
5
Blast Crisis
5
Interventions
Cyclophosphamide
25
Temozolomide
22
Vincristine
18
Irinotecan
18
Doxorubicin
13
Topotecan
10
Melphalan
10
Etoposide
10
Ifosfamide
8
Busulfan
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Filgrastim
6
regorafenib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Sirolimus
5
Radiotherapy
5
Gemcitabine
5
Drug Therapy
5
pegfilgrastim
4
palbociclib
4
liposomal doxorubicin
4
irinotecan sucrosofate
4
ganitumab
4
fludarabine phosphate
4
Trabectedin
4
Phantoms, Imaging
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
thymoglobulin
×
Clear all
NCT02472392
2017-05-09
Ewing/Allo
University of Louisville
Phase 1
Completed
10 enrolled